HETERO LABS LIMITED
Location
Telangana
Founded
1989-03-10
Website
Risk Signals
281 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Pharmaceutical Preparations), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about HETERO LABS LIMITED
Live alerts from global media, monitored by Business Radar
2021-04-27 (economictimes.com)
MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19 -
MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufacturers -- Cipla, Dr Reddy's Laboratories, Emcure Pharmaceuticals, Hetero Labs and Sun Pharmaceutical Industries, it added.
Read more